ARCHIVES

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

This article is from The Cancer Letter archive.

Vol. 18 No. 11 | March 13, 1992

Download PDF Visit The Full Archive

Related Articles

NCI To Require Reports On Adverse Drug Reactions From Trials

June 10, 1994

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990

In congress: Sen. Harkin: “What Causes Cancer” If We Don’t Know The Cause, How Can We Get Into Prevention?

June 27, 1997

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006